12:00 AM
Nov 17, 2003
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Vertex Pharmaceuticals Inc.

(VRTX), Cambridge, Mass.

Business: Cancer, Autoimmune, Infectious

Legg Mason analyst Edward Nash lowered his rating to "buy" from "hold,"...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >